Stabilized uv active organopalladium compounds as vinyl additon catalysts
US-2023038665-A1 · Feb 9, 2023 · US
US11760817B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11760817-B2 |
| Application number | US-202117341850-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 8, 2021 |
| Priority date | Jun 8, 2020 |
| Publication date | Sep 19, 2023 |
| Grant date | Sep 19, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Embodiments in accordance with the present invention encompass compositions comprising a soluble photoacid generator, a organopalladium compound, a photosensitizer and one or more olefinic monomers which undergo vinyl addition polymerization when said composition is exposed to a suitable actinic radiation to form a substantially transparent film. The monomers employed therein have a range of optical and mechanical properties, and thus these compositions can be tailored to form films having various opto-electronic properties. Accordingly, compositions of this invention are useful in various applications, including as coatings, encapsulants, fillers, leveling agents, among others.
Opening claim text (preview).
What is claimed is: 1. A composition comprising: a) a soluble photoacid generator selected from the group consisting of a compound of formula (I): and a compound of formula (II): wherein: a is an integer from 1 to 5; An ⊖ is selected from the group consisting of Cl ⊖ , Br ⊖ , I ⊖ , BF 4 ⊖ , tetrakis(pentafluorophenyl)borate, tetrakis(3,5-bis(trifluoromethyl)phenyl)borate, tetrakis(2-fluorophenyl)borate, tetrakis(3-fluorophenyl)borate, tetrakis(4-fluorophenyl)borate, tetrakis(3,5-difluorophenyl)borate, tetrakis(2,3,4,5-tetrafluorophenyl)borate, tetrakis(3,4,5,6-tetrafluorophenyl)borate, tetrakis(3,4,5-trifluorophenyl)borate, methyltris(perfluorophenyl)borate, ethyltris(perfluorophenyl)borate, phenyltris(perfluorophenyl)borate, tetrakis(1,2,2-trifluoroethylenyl)borate, tetrakis(4-tri-1-propylsilyltetrafluorophenyl)borate, tetrakis(4-dimethyl-tert-butylsilyltetrafluorophenyl)borate, (triphenylsiloxy)tris(pentafluorophenyl)borate, (octyloxy)tris(pentafluorophenyl)borate, tetrakis[3,5-bis[1-methoxy-2,2,2-trifluoro-1-(trifluoromethyl)ethyl]pheny-l]borate, tetrakis[3-[1-methoxy-2,2,2-trifluoro-1-(trifluoromethyl)ethyl]-5-(trifluoromethyl)phenyl]borate, and tetrakis[3-[2,2,2-trifluoro-1-(2,2,2-trifluoroethoxy)-1-(trifluoromethyl)-ethyl]-5-(trifluoromethyl)phenyl]borate, PF 6 ⊖ , SbF 6 ⊖ , n-C 4 F 9 SO 3 ⊖ , CF 3 SO 3 ⊖ and p-CH 3 (C 6 H 4 )—SO 3 ⊖ ; at least one of R 8 , R 9 , R 10 , R 11 and R 12 is selected from the group consisting of linear or branched (C 10 -C 20 )alkyl, (C 6 -C 10 )aryl(C 10 -C 20 )alkyl, (C 10 -C 20 )alkoxy, (C 6 -C 10 )aryloxy(C 10 -C 20 )alkyl, (C 10 -C 20 )alkanoyl(C 6 -C 10 )aryl and (C 10 -C 20 )alkoxy(C 6 -C 10 )aroyl(C 6 -C 20 )alkyl; and the remaining R 8 , R 9 , R 10 , R 11 and R 12 are the same or different and each independently selected from the group consisting of halogen, methyl, ethyl, linear or branched (C 3 -C 20 )alkyl, (C 3 -C 12 )cycloalkyl, (C 6 -C 12 )bicycloalkyl, (C 7 -C 14 )tricycloalkyl, (C 6 -C 10 )aryl, (C 6 -C 10 )aryl(C 1 -C 3 )alkyl, (C 1 -C 12 )alkoxy, (C 3 -C 12 )cycloalkoxy, (C 6 -C 12 )bicycloalkoxy, (C 7 -C 14 )tricycloalkoxy, (C 6 -C 10 )aryloxy(C 1 -C 3 )alkyl, (C 6 -C 10 )-aryloxy, (C 6 -C 10 )thioaryl, (C 1 -C 6 )alkanoyl(C 6 -C 10 )thioaryl, (C 1 -C 6 )alkoxy(C 6 -C 10 )aroyl(C 1 -C 6 )alkyl and (C 6 -C 10 )thioaryl-(C 6 -C 10 )diarylsulfonium salt; b) an organopalladium compound selected from the group consisting of a compound of formula (III), a compound of formula (IIIA) and a compound of formula (IIIB): wherein: L is a ligand selected from the group consisting of P(R) 3 , P(OR) 3 , O═P(R) 3 , RCN and substituted or unsubstituted pyridines, where R is selected from the group consisting of methyl, ethyl, linear or branched (C 3 -C 16 )alkyl, (C 1 -C 16 )perfluoroalkyl, (C 3 -C 10 )cycloalkyl, (C 6 -C 10 )aryl(C 1 -C 16 )alkyl and substituted or unsubstituted (C 6 -C 10 )aryl; each A independently is a bidentate monoanionic ligand of formula (IV): wherein: n is an integer 0, 1 or 2; X and Y are independently of each other selected from O, N and S; R 1 , R 2 , R 3 , R 4 , R 5 , R 6 and R 7 are the same or different and each independently selected from the group consisting of hydrogen, methyl, ethyl, linear or branched (C 3 -C 16 )alkyl, (C 1 -C 16 )perfluoroalkyl, (C 3 -C 10 )cycloalkyl, (C 6 -C 10 )aryl(C 1 -C 16 )alkyl and substituted or unsubstituted (C 6 -C 10 )aryl; provided when either X or Y is O or S, R 1 and R 5 , respectively, do not exist; c) one or more olefinic monomers of the formula (V): wherein: m is an integer 0, 1 or 2; is a single bond or a double bond; at least one of R 13 , R 14 , R 15 and R 16 is selected from the group consisting of linear or branched (C 6 -C 16 )alkyl, (C 6 -C 12 )aryl(C 1 -C 16 )alkyl, (C 6 -C 10 )aryloxy(C 2 -C 16 )alkyl and (C 6 -C 10 )aryl(C 6 -C 10 )aryloxy(C 1 -C 16 )alkyl; the remaining R 13 , R 14 , R 15 and R 16 are the same or different and each independently selected from the group consisting of hydrogen, halogen, a hydrocarbyl or halohydrocarbyl group selected from methyl, ethyl, linear or branched (C 3 -C 16 )alkyl, perfluoro(C 1 -C 12 )alkyl, (C 3 -C 12 )cycloalkyl, (C 6 -C 12 )bicycloalkyl, (C 7 -C 14 )tricycloalkyl, (C 6 -C 10 )aryl, (C 6 -C 10 )aryl(C 1 -C 6 )alkyl, perfluoro(C 6 -C 10 )aryl, perfluoro(C 6 -C 10 )aryl(C 1 -C 6 )alkyl, methoxy, ethoxy, linear or branched (C 3 -C 16 )alkoxy, perfluoro(C 1 -C 12 )alkoxy, (C 3 -C 12 )cycloalkoxy, (C 6 -C 12 )bicycloalkoxy, (C 7 -C 14 )tricycloalkoxy, (C 6 -C 10 )aryloxy, (C 6 -C 10 )aryl(C 1 -C 6 )alkoxy, perfluoro(C 6 -C 10 )aryloxy, perfluoro(C 6 -C 10 )aryl(C 1 -C 3 )alkoxy, wherein: Z is selected from the group consisting of: O, CO, C(O)O, OC(O), OC(O)O, S, (CR 17 R 18 ) b , O(CR 17 R 18 ) b , (CR 17 R 18 ) b O, C(O)(CR 17 R 18 ) b , (CR 17 R 18 ) b C(O), C(O)O(CR 17 R 18 ) b , (CR 17 R 18 ) b C(O)O, OC(O)(CR 17 R 18 ) b , (CR 17 R 18 ) b OC(O), (CR 17 R 18 ) b OC(O)O, (CR 17 R 18 ) b OC(O)O(CR 17 R 18 ) b , OC(O)O(CR 17 R 18 ) b , S(CR 17 R 18 ) b , (CR 17 R 18 ) b S, (SiR 17 R 18 ) b , O(SiR 17 R 18 ) b , (SiR 17 R 18 ) b O, where R 17 and R 18 are the same or different and each independently selected from hydrogen, methyl, ethyl, linear or branched (C 3 -C 12 )alkyl, substituted or unsubstituted (C 6 -C 14 )aryl, methoxy, ethoxy, linear or branched (C 3 -C 6 )alkyloxy, (C 2 -C 6 )acyl, (C 2 -C 6 )acyloxy, and substituted or unsubstituted (C 6 -C 14 )aryloxy; and b is an integer from 0 to 12, inclusive; Aryl is selected from the group consisting of substituted or unsubstituted phenyl, substituted or unsubstituted biphenyl and substituted or unsubstituted naphthyl, substituted or unsubstituted terphenyl, substituted or unsubstituted anthracenyl substituted or unsubstituted fluorenyl, wherein said substituents are selected from the group consisting of halogen, methyl, ethyl, linear or branched (C 3 -C 6 )alkyl, perfluoro(C 1 -C 12 )alkyl, (C 3 -C 12 )cycloalkyl, (C 6 -C 10 )aryl, (C 6 -C 10 )aryl(C 1 -C 6 )alkyl, perfluoro(C 6 -C 10 )aryl, perfluoro(C 6 -C 10 )aryl(C 1 -C 6 )alkyl, methoxy, ethoxy, linear or branched (C 3 -C 16 )alkoxy, perfluoro(C 1 -C 12 )alkoxy, (C 3 -C 12 )cycloalkoxy, (C 6 -C 10 )aryloxy, (C 6 -C 10 )aryl(C 1 -C 6 )alkoxy, perfluoro(C 6 -C 10 )aryloxy and perfluoro(C 6 -C 10 )aryl(C 1 -C 3 )alkoxy; k is an integer from 1 to 12; R 23 , R 24 and R 25 are the same or different and each independently selected from the group consisting of hydrogen, methyl, ethyl, linear or branched (C 3 -C 12 )alkyl, perfluoro(C 1 -C 12 )alkyl, methoxy, ethoxy, linear or branched (C 3 -C 12 )alkoxy, (C 3 -C 12 )cycloalkyl, (C 6 -C 12 )bicycloalkyl, (C 7 -C 14 )tricycloalkyl, (C 6 -C 10 )aryl, (C 6 -C 10 )aryl(C 1 -C 6 )alkyl, perfluoro(C 6 -C 10 )aryl and perfluoro(C 6 -C 10 )aryl(C 1 -C 6 )alkyl; or R 23 and R 24 taken together with the intervening carbon atoms to which they are attached to form a substituted or unsubstituted (C 5 -C 14 )cyclic, (C 5 -C 14 )bicyclic or (C 5 -C 14 )tricyclic ring; and Arylene is substituted or unsubstituted bivalent (C
without C-boron linkages · CPC title
having two condensed rings (coumarone-indene polymers C08F244/00) · CPC title
Compounds having Si-O-C linkages (Si-O-acyl linkages C07F7/1896) · CPC title
Compounds with one or more Si-O-Si sequences (compounds with a ring containing only alternating Si and O atoms, i.e. cyclosilanes C07F7/21) · CPC title
without a metal-carbon linkage · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.